about
Overview of Nrf2 as Therapeutic Target in EpilepsyILAE official report: a practical clinical definition of epilepsyDistinct behavioral phenotypes in novel "fast" kindling-susceptible and "slow" kindling-resistant rat strains selected by stimulation of the hippocampal perforant pathPreoperative automated fibre quantification predicts postoperative seizure outcome in temporal lobe epilepsy.Hughes syndrome and epilepsy: when to test for antiphospholipid antibodies?Identification of prevalent patients with epilepsy using administrative data: the Tuscany experience.Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age: an update.Treatment of epilepsy in China: Formal or informal.Role of oxidative stress in refractory epilepsy: evidence in patients and experimental models.Audit of practice in sudden unexpected death in epilepsy (SUDEP) post mortems and neuropathological findings.Etiology of Sudden Cardiac Arrest in Patients with Epilepsy: Experience of Tertiary Referral Hospital in Sapporo City, Japan.Status epilepticus: Using antioxidant agents as alternative therapies.Automated tractography in patients with temporal lobe epilepsy using TRActs Constrained by UnderLying Anatomy (TRACULA)Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanel.Outcome of seizures in the general population after 25 years: a prospective follow-up, observational cohort study.Pre-seizure state identified by diffuse optical tomographySpotlight on perampanel in the management of seizures: design, development and an update on place in therapy.A novel metabolism-based phenotypic drug discovery platform in zebrafish uncovers HDACs 1 and 3 as a potential combined anti-seizure drug target.Fast noninvasive functional diffuse optical tomography for brain imaging.Adult Prevalence of Epilepsy in Spain: EPIBERIA, a Population-Based Study.Epidemiology of Seizures and EpilepsyThe Epidemiological Characteristics of Epilepsy in the Province of Khyber Pakhtunkhwa, Pakistan
P2860
Q26799344-49DDDAC1-55E6-4545-869C-F954E55C6AA1Q27009103-3E837A76-856B-49C0-BABB-2A7665BCE9DAQ30366924-B4C4052E-97CD-4561-A1D3-6444AFE29397Q30834639-AC33D31F-92B5-4582-9EAC-1B9A5387A97CQ31101744-0A7353FD-7722-4E2E-A030-8212732BBE1AQ31152843-FD1CD67A-8976-42DE-BD1B-EB452D0383D3Q34342674-8E99CE6D-4786-44E3-8B7F-4EC474AD0C08Q35245431-AD893992-5A4C-4999-BA00-BD96237639C3Q36590070-CAB0FA59-02CA-48F5-B0C7-EFB2ED83BDD6Q36892877-DA3365E0-0435-42A3-A764-612748F7E562Q36909528-FC298739-2915-4EB4-B96C-47E1A71AA6AEQ37288222-01916472-59F5-497B-B065-89C7A6D679D9Q37600722-2EDBD28E-571A-4CB3-A5AC-BBF159BA6E95Q38123853-AA732C85-6D6C-4C8C-BCF5-EB6F667235B0Q40093559-A8D04F6D-957B-4CE4-B29B-8D8974D20F5CQ41881225-44FD69F1-8C9D-47E2-B376-0843C387736FQ42373817-A49794AC-3DAA-4077-B16C-C640954601E6Q47709789-281556F3-A7E8-49CC-987C-6F7FF9EA10F3Q47938531-DAFC4BDE-6EB8-476E-B900-3B681C998ED9Q53058760-C76EFDD4-0D2F-4FE8-98B5-D34298822C08Q58449732-C284CA6B-824F-4AEC-8A48-0388B4E5EA0DQ59128375-C1A0E8F8-997E-4470-A7A1-42A5A7A2E2E0
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The epidemiology of the epilepsies.
@ast
The epidemiology of the epilepsies.
@en
The epidemiology of the epilepsies.
@nl
type
label
The epidemiology of the epilepsies.
@ast
The epidemiology of the epilepsies.
@en
The epidemiology of the epilepsies.
@nl
prefLabel
The epidemiology of the epilepsies.
@ast
The epidemiology of the epilepsies.
@en
The epidemiology of the epilepsies.
@nl
P1476
The epidemiology of the epilepsies.
@en
P2093
Aidan Neligan
Willard A Hauser
P304
P356
10.1016/B978-0-444-52898-8.00006-9
P50
P577
2012-01-01T00:00:00Z